Pros | Among most bought funds within the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 4/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 3 Months | 13 Years 3 Months | ||
Fund AUM | ₹3114 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.61% | 0.92% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 34 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.97% | 97.37% | ||
Debt % | - | - | ||
P/E | 36.11 | 35.17 | ||
P/B | 4.82 | 5.57 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -6.31% | -2.84% | ||
3-Month Return | -5.58% | -3.72% | ||
6-Month Return | -4.94% | -2.78% | ||
1-Year Return | -6.09% | 1.67% | ||
3-Year Return | 21.19% | 23.25% | ||
5-Year Return | 15.12% | 15.04% |
Sharpe | 0.98 | 0.97 | ||
Alpha | 0.99 | 0.33 | ||
Beta | 0.85 | 0.9 | ||
Standard Deviation | 14.85 | 15.32 | ||
Information Ratio | -0.26 | -0.32 |
Description | DSP Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Chirag Dagli | Sailesh Raj Bhan, Divya Sharma, Kinjal Desai, Lokesh Maru |